Protagonist Therapeutics, Inc (12)
Browse by Contract Category
Contracts
-
Underwriting Agreement, dated December 10, 2020
(Filed With SEC on December 11, 2020)
-
Severance Agreement, dated August 4, 2020, by and between Protagonist Therapeutics, Inc. and Don Kalkofen
(Filed With SEC on August 6, 2020)
-
Description of Protagonist Therapeutics, Inc.s Securities Registered Pursuant to Section 12 of the Exchange Act
(Filed With SEC on March 10, 2020)
-
First Amendment to Exclusive License and Collaboration Agreement, by and between Protagonist Therapeutics, Inc. and Janssen Biotech, Inc., dated May 7, 2019
(Filed With SEC on August 7, 2019)
-
First Amendment, dated January 31, 2019, to Lease, dated March 6, 2017, by and between Protagonist Therapeutics, Inc., as Tenant, and BMR-Pacific Research Center LP
(Filed With SEC on May 8, 2019)
-
Underwriting Agreement, dated as of May 11, 2020
(Filed With SEC on May 12, 2020)
-
Protagonist Therapeutics, Inc. Amended and Restated 2018 Inducement Plan
(Filed With SEC on February 24, 2020)
-
Open Market Sale AgreementSM, dated November 27, 2019, by and between Protagonist Therapeutics, Inc. and Jefferies LLC
(Filed With SEC on November 27, 2019)
-
Severance Agreement, dated July 19, 2019, by and between Protagonist Therapeutics, Inc. and Samuel Saks, M.D
(Filed With SEC on November 6, 2019)
-
Offer Letter between Protagonist Therapeutics, Inc. and Donald Kalkofen, dated May 20, 2019
(Filed With SEC on May 29, 2019)
-
Separation Agreement between Protagonist Therapeutics, Inc. and Richard S. Shames, dated May 7, 2019
(Filed With SEC on May 13, 2019)
-
Severance Agreement, dated March 14, 2019, by and among Protagonist Therapeutics, Inc. and Suneel Gupta, Ph.D
(Filed With SEC on May 8, 2019)